Lucely Cetina - Concepedia

Author

Lucely Cetina

Instituto Nacional de Cancerología ORCID

Also Known As

Cetina Pérez, L Cetina, L. CETINA, L. Cetina, L. Cetina-Pèrez, L. Cetina-Pérez, L.D.C. Cetina-Pérez, Lucely Cetina, Lucely Cetina-Perez, Lucely Cetina-Pérez

111

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cancerología Universidad Nacional Autónoma de México Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Clinical Research Management Universidad de Cuautitlán Izcalli

About

Lucely Cetina is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	911
2	Public Health	4	4	174
3	Health Sciences	2	2	40
4	Allergy	1	1	11
5	Clinical Nutrition	1	1	10

Lucely Cetina

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce, Annals of Oncology Chemotherapy ResistanceMedicinePharmacologyMagnesium ValproatePharmacotherapy	2007	249
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes Pilar Zambrano, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas, BMC Cancer	2005	150
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results Jaime Coronel, Lucely Cetina, Irlanda Pacheco, Medical Oncology Advanced Cervical CancerCervical CancerMedicinePharmacologyClinical Trials	2010	131
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study Alma Chávez‐Blanco, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas, Molecular Cancer	2005	127
Radiosensitizers in cervical cancer. Cisplatin and beyond Myrna Candelaria, Alicia Garcia-Arias, Lucely Cetina, Radiation Oncology Advanced Cervical CancerRadiation MedicineCervical CancerRadiation TherapyMedicine	2006	107
A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation Alfonso Dueñas‐González, C. López‐Graniel, Aarón González-Enciso, Annals of Oncology Advanced Cervical CancerCervical Cancer ManagementSurgical OncologyCervical CancerMedicine	2003	96
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients Lucely Cetina, Aarón González-Enciso, Jaime Coronel, Annals of Oncology Surgical OncologyRadiation MedicineCervical CancerRadiation TherapyMedicine	2013	82
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized Phase II study Alfonso Dueñas‐González, Lucely Cetina, C. López‐Graniel, International Journal of Radiation OncologyBiologyPhysics Toxicity AssessmentOncologyCervical CancerRadiation TherapyMedicine	2005	74
Human Papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients David Cantú de León, Delia Pérez‐Montiel, Jana Němcová, BMC Cancer	2009	74
HER2 expression in cervical cancer as a potential therapeutic target Alma Chávez‐Blanco, Víctor M. Pérez-Sánchez, Aurora González‐Fierro, BMC Cancer	2004	65

Page 1